Does Rallies show Form 4 insider transactions for CLPT?

Yes. Rallies tracks CLPT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CLPT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLPT. It does not provide personalized investment advice.

CLPT (ClearPoint Neuro, Inc. Common Stock) Stock Analysis - Insider Trades

ClearPoint Neuro, Inc. Common Stock (CLPT) is a publicly traded Healthcare sector company. As of May 19, 2026, CLPT trades at $11.15 with a market cap of $349.08M and a P/E ratio of -15.82. CLPT moved -4.55% today. Year to date, CLPT is -20.67%; over the trailing twelve months it is -15.55%. Its 52-week range spans $8.27 to $30.10. Analyst consensus is strong buy with an average price target of $22.00. Rallies surfaces CLPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CLPT stock inside the company?

Recent CLPT insider activity includes BURNETT JOSEPH sold 19.95K, BURNETT JOSEPH sold 2.94K, BURNETT JOSEPH sold 20.00K, BURNETT JOSEPH sold 17.58K, and BURNETT JOSEPH sold 6.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CLPT Key Metrics

Key financial metrics for CLPT
Metric	Value
Price	$11.15
Market Cap	$349.08M
P/E Ratio	-15.82
EPS	$-0.70
Dividend Yield	0.00%
52-Week High	$30.10
52-Week Low	$8.27
Volume	35
Avg Volume	0
Revenue (TTM)	$31.39M
Net Income	$-18.91M
Gross Margin	60.92%

Recent CLPT Insider Trades

BURNETT JOSEPH sold 19.95K (~$302.66K) on Feb 25, 2026.
BURNETT JOSEPH sold 2.94K (~$45.82K) on Jan 26, 2026.
BURNETT JOSEPH sold 20.00K (~$322.40K) on Jan 9, 2026.
BURNETT JOSEPH sold 17.58K (~$466.13K) on Oct 10, 2025.
BURNETT JOSEPH sold 6.60K (~$182.40K) on Oct 10, 2025.

Latest CLPT News

ClearPoint Posts Record Q1 Revenue; Cash Down to $35.6M, 175+ Sites — May 19, 2026
ClearPoint Neuro Posts 43% Q1 Revenue Growth to $12.1M, Margin Rises to 64% — May 13, 2026
ClearPoint Neuro’s 80,000 rpm MR Drill Clears FDA, Cuts Procedure Time — Apr 22, 2026
ClearPoint Neuro Wins Canadian Medical Device License for Navigation, Expands 34-Country Network — Apr 20, 2026

CLPT Analyst Consensus

3 analysts cover CLPT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.00.

Common questions about CLPT

Who is trading CLPT stock inside the company?: Recent CLPT insider activity includes BURNETT JOSEPH sold 19.95K, BURNETT JOSEPH sold 2.94K, BURNETT JOSEPH sold 20.00K, BURNETT JOSEPH sold 17.58K, and BURNETT JOSEPH sold 6.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CLPT?: Yes. Rallies tracks CLPT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CLPT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLPT. It does not provide personalized investment advice.